Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 6/20 | 0.67 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.67 |
| ▸ | CCNC | P24863 | 4/20 | 0.59 |
| ▸ | CDK8 | P49336 | 4/20 | 0.59 |
| ▸ | GABRP | O00591 | 3/20 | 0.56 |
| ▸ | GABRD | O14764 | 3/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.56 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.56 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.56 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.56 |
| ▸ | GABRE | P78334 | 3/20 | 0.56 |
| ▸ | GABRA6 | Q16445 | 3/20 | 0.56 |
| ▸ | GABRG1 | Q8N1C3 | 3/20 | 0.56 |
| ▸ | GABRG3 | Q99928 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lanceolatin B SCHEMBL1161113 | 0.78 | CYP1B1 (1.00) | CYP1A1CYP1B1CYP1A2GABRPGABRD | |
| Norwogonin SCHEMBL30485998 | 0.77 | GABRP (0.68) | CYP1A1CYP1B1CYP1A2CCNCCDK8 | |
| Norwogonin SCHEMBL760431 | 0.77 | GABRP (0.68) | CYP1A1CYP1B1CYP1A2CCNCCDK8 | |
| SCHEMBL4783697 | 0.77 | ALDH1A1 (0.67) | CYP1A1CYP1B1CYP1A2CCNCCDK8 | |
| SCHEMBL28066043 | 0.75 | GABRP (0.65) | CYP1A1CYP1B1CYP1A2CCNCCDK8 | |
| SCHEMBL29149073 | 0.75 | GABRP (0.70) | CYP1A1CYP1B1CYP1A2CCNCCDK8 | |
| SCHEMBL28762706 | 0.75 | CCNC (1.00) | CYP1A1CYP1B1CYP1A2CCNCCDK8 | |
| SCHEMBL21145431 | 0.73 | GABRP (0.62) | CYP1A1CYP1B1CYP1A2CCNCCDK8 | |
| SCHEMBL27719536 | 0.73 | PPARG (0.68) | CYP1A1CYP1B1CYP1A2CCNCCDK8 | |
| SCHEMBL8934562 | 0.72 | MEN1 (0.67) | CYP1A1CYP1B1CYP1A2CCNCCDK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | TerViva BioEnergy, Inc. (US) | 2026-04-28 | — | — | US | claimed |
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | TerViva BioEnergy, Inc. (US) | 2026-04-28 | — | — | US | disclosed |
| US-12052994-B2 | Methods for controlling black sigatoka in bananas using pongamia oil and formulations thereof | Terviva, Inc. (US) | 2024-08-06 | — | — | US | disclosed |
| CN-113473863-B | Method for controlling black leaf spot in bananas using water yellow oil and its formulation | 特尔维瓦股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20220369662-A1 | EDIBLE PONGAMIA COMPOSITIONS, AND METHODS OF PREPARING AND USING THEREOF | Terviva, Inc. (US) | 2022-11-24 | — | — | US | disclosed |
| EP-4037491-A1 | EDIBLE PONGAMIA COMPOSITIONS, AND METHODS OF PREPARING AND USING THEREOF | TerViva, Inc. (US) | 2022-08-10 | — | — | EP | disclosed |
| US-20220125059-A1 | METHODS FOR CONTROLLING BLACK SIGATOKA IN BANANAS USING PONGAMIA OIL AND FORMULATIONS THEREOF | Terviva, Inc. (US) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220125059-A1 | METHODS FOR CONTROLLING BLACK SIGATOKA IN BANANAS USING PONGAMIA OIL AND FORMULATIONS THEREOF | LIPA, SIGLEC7, AMY1A | CYP1A1 3611/4885CYP1B1 3816/4885CYP1A2 2668/4885 |
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | DEK, DGKG, SRMS | CYP1A1 2801/4885CYP1B1 3735/4885CYP1A2 2420/4885 |
| US-12052994-B2 | Methods for controlling black sigatoka in bananas using pongamia oil and formulations thereof | LIPA, SIGLEC7, AMY1A | CYP1A1 3611/4885CYP1B1 3816/4885CYP1A2 2668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.